Atreca Inc BCEL

Alternate Symbol(s): COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. It commenced clinical development of ATRC-101 with a Phase Ib clinical trial evaluating ATRC-101 as a monotherapy in patients with select solid tumors and opens a new cohort to evaluate ATRC-101 in combination with pembrolizumab, a PD-1 checkpoint inhibitor. It is also advancing additional product candidates using its discovery platform. Its oncology programs include APN-497444, an ADC against a tumor glycan target, and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target.

PINL:BCEL - Post by User

Atreca Inc

Bullboard Posts

Comment by TheHoboon Mar 26, 2010 10:01am

370 Views

Post# 16927337

RE: RE: RE: Where Is There Support?

Coomigasp has posted that the President can't make it due to commitments elsewhere in the world; and rather than mobilize the 50k miners twice they are going to reconvene at an as yet undetermined date for both announcements.

I'm long on this and made a lot of money, but there's still tons to be made. Will it be 8 bucks by the end of next week? Probably not; but I'm not here for just 8 bucks anyways :)

Bullboard Posts

This gambling tech stock might be the safest bet you’ll make this year